Gila Therapeutics

Gila Therapeutics is a Boston-based clinical-stage biotechnology company that utilizes a novel, highly targeted neurosignaling system to treat obesity, type 2 diabetes, and related metabolic disorders. The scientific advisory team of Gila Therapeutics is globally renowned for their unparalleled expertise and groundbreaking contributions in the fields of endocrinology, neuroscience, and metabolic nephrology.